EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, COGT: Cogent Biosciences Inc

16 Jan 26 15:59
LAST:

38.91

CHANGE:
 0.31		OPEN:
39.83		HIGH:
41.35		ASK:
4.20		VOLUME:
1.29M
CHG(%):
0.79		PREV:
39.25		LOW:
38.59		BID:
15.02		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Jan 2639.5741.3538.5938.942.31M
15 Jan 2637.7539.3036.8839.252.96M
14 Jan 2635.5238.3635.0937.791.93M
13 Jan 2634.6836.2534.2635.282.1M
12 Jan 2634.6035.1433.8434.761.46M
09 Jan 2636.0036.8835.2835.352.25M
08 Jan 2635.4736.0634.6135.571.93M
07 Jan 2635.2237.0134.5036.273.44M
06 Jan 2634.4635.0833.7534.782.7M
05 Jan 2634.5934.7432.9334.263.16M

PROFILE

Name:Cogent Biosciences Inc
About:Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:275 Wyman Street, Waltham, MA, United States, 02451
Website:https://www.cogentbio.com
CUSIP:19240Q201
CIK:0001622229
ISIN:US19240Q2012
FIGI:BBG007DHZQR7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.69 
Forward P/E:-20.61 
PEG Ratio:-0.71 
Price to Sales:1,320.63 
Price to Book:26.07 
Return on Assets:-0.53 
Return on Equity:-1.08 
EPS Ratio:-2.05 
Shares:153.51M 
Market Cap:5.973B 

TECHNICAL INDICATORS

MA5:37.204.6%
MA10:36.237.4%
MA20:37.164.7%
MA50:36.087.9%
MA100:25.1654.6%
MA200:16.47136.3%
STO9:63.43
STO14:66.01
RSI14:50.23
WPR14:-6.21 
MTM14:1.02
ROC14:0.03 
ATR:2.05 
Week High:41.356.3%
Week Low:33.8415.0%
Month High:41.356.3%
Month Low:32.93136.3%
Year High:43.7312.4%
Year Low:3.72946.0%
Volatility:7.97 

RECENT SPLITS

Date Ratio
09 Nov 20201-4
27 Mar 20182-15